Canada markets open in 3 hours 16 minutes

Ionis Pharmaceuticals, Inc. (IONS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
43.88-0.44 (-0.99%)
At close: 04:00PM EDT
44.80 +0.92 (+2.10%)
After hours: 05:24PM EDT

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • M
    I don't think that IONS has another 10% in gains in it. Looks pretty bad here. I actually found ( the other day and their stocks are way better...
  • J
    Something is brewing with IONS, possibly takeover target by big Pharma/Bio ?
  • s
    Go baby go!!!!!!
  • B
    This Bayer relationship was my reason for getting into IONS. The market for an anti-coagulant that prevents clotting without causing bleeding is enormous! Glad to finally see some results on it.
  • s
  • R
    Is there any news that can move this stock.
  • F
    Two consecutive days of big gains! Company still way undervalued considering all clinical programs, more than thousands of patents in the RNA/Antisense space and readouts in the nearer future. Do absolutely not agree that Ionis is no buyout candidate which was always argued referring to multiple partnerships which make it much more complicated for an acquiring company. BNTX and/or MRNA may be interested to add huge RNA expertise and a phenomenal patent library as well as IONS owned development programs without having an issue with other partnerships with pharmaceutical companies such as Astra Zeneca, BIIB, Novartis etc. Just a few thoughts.
    Long-term bullish!
  • M
    Huh? Why the big jump today?
  • L
    Just heard that IONS got alerted at ( I hope it pushes us higher!
  • b
    congrats to buyers <30
    will be starting position tomorrow and dips ..

    this is long term hold and will brought out ...

  • P
    No volume but up. Strange!!
  • B
    Insiders are buying.
  • I
    I Hate Wabbits
    Stoked by the phase 3 mono therapy announcement for HBV.
  • j
    Alnylam up that's why
  • F
    Always positive results and never a drug since 1996. One of the greatest get a ways in the history of biotechs.

    Name just one ? It's darkouttonight.
  • M
    Things starting to finally click for this company. OK, so I’ve been holding and buying for over 20 years (after making $$ on Medimune). Gonna hold for a few more years until SS kicks in, hopefully by then it will have doubled or more from where it is now. Good luck longs.
  • B
    Gene Editing Positions :

    New job posting's June 7TH. 2022

    Looking for TWO Senior Scientist - Gene Editing Core Research

    IONIS Hired a Director of Gene Editing Core Research last month (May)

    The GT platform is called: I - Edit

    when I get a chance I will post his/her Job description. Looks like Ionis has been working in this area for a while as there are I- Edit teams in place per the job description.

    Remember they did some Crisper technology enhancement delivery work 5 years ago or so that got shelved.
  • z
    Thanks, I'll check them out.Thanks for the tip!Thanks for the update!
  • B
    I -Edit job posting

    Director/Executive Director of Formulation and Delivery Sciences

    The candidate will direct formulation efforts within a new drug discovery thrust at Ionis in gene editing known as I -Edit

    Ionis is developing a New Drug Delivery platform no if and or buts
  • F
    Lilly lost over 300 mil and many jobs. I could mention many more biotechs that their scientist thought they could fit a round hole into a square . Thus , ended up with a seven year job etc. Just standard operating procedure. biib one of a long line. I can only save so many kids so got to it. Some insiders called me Dr. A. Dorr.

    Darkouttonight will do and sorry I don't have more time to spend. Your welcome.